Literature DB >> 26097609

Assoication of XRCC1 gene polymorphisms with risk of non-small cell lung cancer.

Shirong Kang1, Ying Ma2, Caixia Liu3, Chunli Cao4, Jiafeng Qi5, Jiwei Li6, Xu Wu6.   

Abstract

DNA repair genes is a key factor for cancer susceptibility, and we conducted a case-control study to investigate the association of XRCC1 codons 194 (Arg to Trp), 280 (Arg to His) and 399 (Arg to Gln) with risk of NSCLC. 210 NSCLC patients and 210 health control subjects were randomly selected from Huaihe Hospital between January 2012 and June 2014. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was taken to assess the genotyping of XRCC1 Arg194Trp, Arg280His and Arg399Gln. By multivariate logistic regression analysis, we found individuals carrying with Trp/Trp and Arg/Trp + Trp/Trp genotypes were associated with a significantly increased risk of NSCLC compared with Arg/Arg genotype, and the OR (95% CI) were 3.15 (1.32-8.09) and 1.52 (1.02-2.28), respectively. The potential association of Arg/Trp+ Trp/Trp genotype of XRCC1 Arg194Trp with the risk of NSCLC is more evidence in smokers, and the OR (95% CI) was 1.78 (1.01-3.24). In conclusion, we found that XRCC1 Arg194Trp polymorphism may be associated with NSCLC risk, especially in smokers.

Entities:  

Keywords:  XRCC1; non-small cell lung cancer; polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26097609      PMCID: PMC4466996     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

Review 1.  Genome maintenance mechanisms for preventing cancer.

Authors:  J H Hoeijmakers
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 2.  Genetic susceptibility to lung cancer: the role of DNA damage and repair.

Authors:  Margaret R Spitz; Qingyi Wei; Qiong Dong; Christopher I Amos; Xifeng Wu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-08       Impact factor: 4.254

3.  Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function.

Authors:  Tong Xi; Irene M Jones; Harvey W Mohrenweiser
Journal:  Genomics       Date:  2004-06       Impact factor: 5.736

Review 4.  Leisure-time physical activity and lung cancer: a meta-analysis.

Authors:  Adonina Tardon; Won Jin Lee; Miguel Delgado-Rodriguez; Mustafa Dosemeci; Demetrius Albanes; Robert Hoover; Aaron Blair
Journal:  Cancer Causes Control       Date:  2005-05       Impact factor: 2.506

5.  Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein.

Authors:  Y Kubota; R A Nash; A Klungland; P Schär; D E Barnes; T Lindahl
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

6.  Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.

Authors:  Q Wei; L Cheng; C I Amos; L E Wang; Z Guo; W K Hong; M R Spitz
Journal:  J Natl Cancer Inst       Date:  2000-11-01       Impact factor: 13.506

Review 7.  Cisplatin in advanced cancer of the cervix: an update.

Authors:  D S Alberts; D Garcia; N Mason-Liddil
Journal:  Semin Oncol       Date:  1991-02       Impact factor: 4.929

8.  Human DNA repair genes.

Authors:  R D Wood; M Mitchell; J Sgouros; T Lindahl
Journal:  Science       Date:  2001-02-16       Impact factor: 47.728

9.  Smoking, DNA repair capacity and risk of nonsmall cell lung cancer.

Authors:  Hongbing Shen; Margaret R Spitz; Yawei Qiao; Zhaozheng Guo; Li-E Wang; Carol H Bosken; Christopher I Amos; Qingyi Wei
Journal:  Int J Cancer       Date:  2003-10-20       Impact factor: 7.396

10.  Association between genetic polymorphisms in XPD and XRCC1 genes and risks of non-small cell lung cancer in East Chinese Han population.

Authors:  Yong Du; Yanchao He; Zhoufang Mei; Ling Qian; Jindong Shi; Zhijun Jie
Journal:  Clin Respir J       Date:  2014-11-03       Impact factor: 2.570

View more
  2 in total

1.  Application of gene polymorphisms to predict the sensitivity of patients with locally advanced non-small cell lung cancer undergoing chemoradiotherapy.

Authors:  Yue Zhao; Yun Xie; Dianjun Jia; Chiluan Ma; Dongdong Wei; Xiaoyu Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  Association Between COX-2 Polymorphisms and Lung Cancer Risk.

Authors:  Weiwei Wang; Xinyun Fan; Yong Zhang; Yi Yang; Siyuan Yang; Gaofeng Li
Journal:  Med Sci Monit       Date:  2015-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.